These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25043303)

  • 1. Phosphorylation of Dok1 by Abl family kinases inhibits CrkI transforming activity.
    Ng KY; Yin T; Machida K; Wu YI; Mayer BJ
    Oncogene; 2015 May; 34(20):2650-9. PubMed ID: 25043303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteins that bind the Src homology 3 domain of CrkI have distinct roles in Crk transformation.
    Zheng J; Machida K; Antoku S; Ng KY; Claffey KP; Mayer BJ
    Oncogene; 2010 Dec; 29(48):6378-89. PubMed ID: 20729917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dok1 and SHIP act as negative regulators of v-Abl-induced pre-B cell transformation, proliferation and Ras/Erk activation.
    Oki S; Limnander A; Yao PM; Niki M; Pandolfi PP; Rothman PB
    Cell Cycle; 2005 Feb; 4(2):310-4. PubMed ID: 15655368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Abl phosphorylates Dok1 to promote filopodia during cell spreading.
    Woodring PJ; Meisenhelder J; Johnson SA; Zhou GL; Field J; Shah K; Bladt F; Pawson T; Niki M; Pandolfi PP; Wang JY; Hunter T
    J Cell Biol; 2004 May; 165(4):493-503. PubMed ID: 15148308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crk family adaptor proteins trans-activate c-Abl kinase.
    Shishido T; Akagi T; Chalmers A; Maeda M; Terada T; Georgescu MM; Hanafusa H
    Genes Cells; 2001 May; 6(5):431-40. PubMed ID: 11380621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation.
    Sriram G; Reichman C; Tunceroglu A; Kaushal N; Saleh T; Machida K; Mayer B; Ge Q; Li J; Hornbeck P; Kalodimos CG; Birge RB
    Oncogene; 2011 Nov; 30(46):4645-55. PubMed ID: 21602891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
    Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel member of the DOK family that binds and modulates Abl signaling.
    Cong F; Yuan B; Goff SP
    Mol Cell Biol; 1999 Dec; 19(12):8314-25. PubMed ID: 10567556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles for Crk adaptor isoforms in actin reorganization induced by extracellular signals.
    Antoku S; Mayer BJ
    J Cell Sci; 2009 Nov; 122(Pt 22):4228-38. PubMed ID: 19861495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.
    Mihrshahi R; Brown MH
    J Immunol; 2010 Dec; 185(12):7216-22. PubMed ID: 21078907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.
    Ren R; Ye ZS; Baltimore D
    Genes Dev; 1994 Apr; 8(7):783-95. PubMed ID: 7926767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
    Mayer BJ; Baltimore D
    Mol Cell Biol; 1994 May; 14(5):2883-94. PubMed ID: 8164650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Dok-1 and Dok-2 in leukemia suppression.
    Niki M; Di Cristofano A; Zhao M; Honda H; Hirai H; Van Aelst L; Cordon-Cardo C; Pandolfi PP
    J Exp Med; 2004 Dec; 200(12):1689-95. PubMed ID: 15611295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
    Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
    Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
    Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of c-Crk II on the negative regulatory Tyr222 mediates nerve growth factor-induced cell spreading and morphogenesis.
    Escalante M; Courtney J; Chin WG; Teng KK; Kim JI; Fajardo JE; Mayer BJ; Hempstead BL; Birge RB
    J Biol Chem; 2000 Aug; 275(32):24787-97. PubMed ID: 10825157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the dok1 phosphoprotein in bcr-Abl transformed cells.
    Dunant NM; Wisniewski D; Strife A; Clarkson B; Resh MD
    Cell Signal; 2000 May; 12(5):317-26. PubMed ID: 10822173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
    Jung JH; Pendergast AM; Zipfel PA; Traugh JA
    Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes.
    Kain KH; Klemke RL
    J Biol Chem; 2001 May; 276(19):16185-92. PubMed ID: 11279004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Abl kinase regulates the protein binding activity of c-Crk.
    Feller SM; Knudsen B; Hanafusa H
    EMBO J; 1994 May; 13(10):2341-51. PubMed ID: 8194526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.